COMMUNIQUÉS West-GlobeNewswire

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
14/02/2024
Bagsværd, Denmark, 14 February 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance [...]
Larimar Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock
14/02/2024
BALA CYNWYD, Pa., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today [...]
Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference Call
14/02/2024
VANCOUVER, British Columbia, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the [...]
Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01
14/02/2024
STAFFORD, Texas, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to [...]
Grifols announces positive topline phase 3 fibrinogen clinical trial results
14/02/2024
In the AdFIrst study, Biotest's fibrinogen concentrate (FC), BT524, met the primary endpoint, demonstrating its effectiveness in treating acquired fibrinogen deficiency (AFD) as equivalent to standard of care, while [...]
Numab Therapeutics and Ono Pharmaceutical Announce an Option and Collaboration Agreement to Develop Multi-specific Antibody NM49 for Treatment of Cancer
14/02/2024
NM49 is a multi-specific antibody identified through Numab’s proprietary discovery and engineering technology platform designed to activate tumor associated macrophage phagocytosis Numab to receive upfront payment and [...]
Iktos opens a subsidiary in Japan and entrusts its management to Hideyoshi Fuji
14/02/2024
Paris (France) and Tokyo (Japan), February 14, 2024 – Iktos, a company specialized in Artificial Intelligence for new drug design, announces the opening of Iktos K.K., its new subsidiary in Japan. Hideyoshi Fuji has [...]
TILT Biotherapeutics Awarded USD 2M Grant from US Department of Defense for Ovarian Cancer Immunotherapy Research
14/02/2024
Project Grant for Development of Company’s Lead Clinical Program HELSINKI, Finland, Feb. 14, 2024 (GLOBE NEWSWIRE) -- TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies [...]
Mendus AB Year-end Report for 2023
14/02/2024
Press Release Stockholm, Sweden, February 14, 2024 Positive ADVANCE II data at ASH caps strong 2023 The fourth quarter of 2023 closes a crucial year for Mendus and delivered additional milestones to further strengthen [...]
Santhera Announces Publication of Efficacy, Safety and Tolerability Data with Vamorolone (AGAMREE®) in Patients with Duchenne Muscular Dystrophy in Neurology
14/02/2024
Results from 112 patients with DMD who completed the study confirm maintenance of efficacy and benefits in safety and tolerability of treatment with vamorolone over 48 weeks AGAMREE® has shown safety benefits in [...]
PCI Biotech second half 2023 interim results
14/02/2024
Oslo (Norway), 14 February 2024 – PCI Biotech (OSE: PCIB), today announces its interim second half 2023 results. Please find enclosed the interim report and presentation. Highlights review Operations The use of fima NAc [...]
Ultimovacs ASA Reports Fourth Quarter 2023 Financial Results and Provides General Business Update
14/02/2024
Readout of topline result expected in March 2024 from UV1 randomized Phase II trial INITIUM in Ultimovacs’ lead indication, advanced malignant melanoma Topline result will report primary endpoint of progression-free [...]
Ibogaine By David Dardashti Encourages Couples to Get Clean Together This Valentine's Day
14/02/2024
Research on the bond of couples who get clean together MIAMI, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti, a leading addiction recovery clinic, is proud to present their research on couples who get [...]
NewAmsterdam Pharma Announces Pricing of $175.3 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
14/02/2024
NAARDEN, the Netherlands and MIAMI, Feb. 13, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS ; “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, [...]
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14/02/2024
IRVINE, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that the Company’s Compensation Committee granted 42,500 restricted stock units (RSUs) and stock [...]
Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2024
13/02/2024
FDA approved LIKMEZ™ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL Additional USAFA funding commitment from the U.S. Air Force Academy, intended to advance the ATI-1701 program toward an IND submission to the [...]
Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
13/02/2024
AUDUBON, Pa., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31 [...]
Metagenomi Announces Closing of Initial Public Offering
13/02/2024
EMERYVILLE, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive [...]
Natural Alternatives International, Inc. Announces 2024 Q2 and YTD Results
13/02/2024
CARLSBAD, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today [...]

Pages